NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹314.9 Cr | -11.8% | 1.4% | -61.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,077.0 Cr | 2.8% | 6.3% | -1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,324.0 Cr | -2.1% | -2.5% | 12.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,235.0 Cr | -2.5% | 4.2% | 21.5% | Stock Analytics | |
| CIPLA | ₹123,294.0 Cr | 0% | -3.3% | 0.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,336.0 Cr | 1.3% | -0.5% | -0.2% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | -11.8% |
1.4% |
-61.2% |
| SENSEX | 0.9% |
2.1% |
8.3% |
You may also like the below Video Courses